![Bas Vaessen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bas Vaessen
Consigliere Generale presso
LSP Management Group BV
Profilo
Bas Vaessen is General Counsel in the EQT Life Sciences team.
Bas worked for LSP from 2008 until 2022, when LSP joined forces with EQT and was renamed EQT Life Sciences.
Prior to joining LSP, Bas worked as Legal Counsel at Corbion in Amsterdam, the Netherlands.
Prior to that, Bas was a lawyer in the corporate law department of the international law form Hogan Lovells in Amsterdam, the Netherlands.
Bas holds a master’s degree in civil law from the Erasmus University of Rotterdam, the Netherlands.
Posizioni attive di Bas Vaessen
| Società | Posizione | Inizio |
|---|---|---|
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Consigliere Generale | 01/01/2008 |
Precedenti posizioni note di Bas Vaessen
| Società | Posizione | Fine |
|---|---|---|
| CORBION N.V. | Consigliere Generale | 01/01/2008 |
Formazione di Bas Vaessen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
93
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Corbion NV
 Corbion NV Food: Specialty/CandyConsumer Non-Durables Produces and supplies synthetic ingredients, biomedical polymer & natural alternatives | Consumer Non-Durables |
LSP Management Group BV
LSP Management Group BV Investment ManagersFinance EQT Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, medical devices, diagnostics and healthtech sectors. It provides financing for early and later stage capital requirements with an investment size of EUR 10 – 60 million. | Finance |
Erasmus University Rotterdam
 Erasmus University Rotterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
